NASDAQ:FLXN

Flexion Therapeutics Earning Date

USA |NASDAQ |USD

FLXN Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 2, 2021 Sep 2021 $-0.42 $-0.44 $-0.50
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 2, 2021 Sep 2021 $33.42M $28.18M $23.66M

Flexion Therapeutics's next earnings date is Tuesday, Nov 2, 2021 for the fiscal quarter ending Sep 2021.

FLXN Earnings Date & History Chart

FLXN Earnings & Revenue Forecast

FLXN Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 10 $-0.37 $-0.45 $-0.26
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 11 $-1.77 $-1.93 $-1.29
Dec 2022 11 $-0.77 $-1.41 $0.62

FLXN Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.37 $-0.40 $-0.40
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.77 $-1.89 $-1.89
Dec 2022 0 / 0 $-0.77 $-0.77 $-0.77

FLXN Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 9 $38.14M $35.00M $42.39M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 11 $131.68M $119.80M $205.20M
Dec 2022 11 $197.48M $169.06M $288.40M

FLXN Earnings Date & Revenue History

FLXN Earnings History

|
Show More
Show More

FLXN Revenue History

|
Show More
Show More

Flexion Therapeutics Next Earnings Date & Report

FLXN Next Earnings Date & Report Preview: Sep 2021 (FQ)

FLXN's next earnings date is Tuesday, Nov 2, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 10 analysts, the average EPS estimation for Flexion Therapeutics's next quarterly earnings is $-0.42, with a low EPS estimation of $-0.46, and a high estimation of $-0.33.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.42, the last 2 month trend is $-0.46, and the 3 month trend is $-0.46.

Based on 8 analysts, the average revenue estimation is $33.42M, with a low revenue estimation of $31.03M, and a high estimation of $36.00M.

Flexion Therapeutics Previous Earnings Dates & Reports

FLXN Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Flexion Therapeutics's previous earnings date was Aug 4, 2021 for its fiscal quarter ended Jun 30, 2021.

FLXN's earnings per share (EPS) was $-0.44, beating the consensus analysts forecast of $-0.50 by 12.00%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -22.81%, and higher than the same period a year before (Jun 2020) by -42.11%.

Revenues were $28.18M, better than the forecast of $28.18M by 0.00%, up by 14.58% from the previous quarter , and up by 82.35% from the same period last year.

The company reported a net income of $-22.21M.

Free cash flow for the quarter was $-19.23M , compared to $-19.27M last quarter and $-22.70M a year before.

FLXN ended the quarter with $228.90M in total debt, a decrease of -0.76% compared to the previous quarter, and an increase of 4.78% compared to the same quarter a year before.

FLXN Previous Earnings Date & Report Recap: Dec 2020 (FY)

Flexion Therapeutics's previous annual earnings date was Mar 10, 2021 for its fiscal year ended Dec 31, 2020.

FLXN's earnings per share (EPS) was $-2.53, beating the consensus analysts forecast of $-2.65 by -4.53% , and higher than the previous year's EPS (Dec 2019) by -35.46%.

Revenues were $85.55M, worse than the forecast of $88.74M by -3.59%, and up by 17.26% from previous year's revenue.

The company reported a net income of $-113.71M.

Flexion Therapeutics reported a free cash flow of $-80.63M for its fiscal year, compared to $-152.65M a year ago.

The company ended the fiscal year with $225.23M in total debt, an increase of 15.54% compared to the previous year.